What Happened?
Durham, NC-based Precision-Bioscience Appointed Matthew Kane as Chief Executive Officer
About the Company
Precision Biosciences is a publicly held biotechnology company dedicated to improving life through its next generation gene editing technology, ARCUS. Precision`s cell therapy, gene therapy, and agriculture programs are based on the proprietary ARCUS gene editing platform, which features coordinated target site binding and DNA cutting to ensure precise edits. Our team includes pioneers in genome engineering, biotech business leaders, and a growing staff of committed Precisioneers. We work together in our beautifully designed, award-winning space in vibrant downtown Durham, NC; a place with great restaurants and museums as well as fantastic housing and schools. Precision provides all employees a sense of purpose, thoughtfully designed laboratory and office spaces, and opportunities to train and grow – not to mention plentifully stocked kitchens and fantastic benefits. At Precision Biosciences, we are excited to work together toward improving lives by realizing the potential of gene editing.
About the Person
Matthew Kane is Chief Executive Officer at Precision Bioscience. Previously, Matthew held various senior HR leadership roles in the industry.
Info Source
News
Short Profile